University of Washington
Nicole Mayer Hamblett, PhD, is a Professor of Pediatrics and Adjunct Professor of Biostatistics at the University of Washington. She is the Co-Executive Director of the Cystic Fibrosis Therapeutics Development Network (CF TDN) Coordinating Center at Seattle Children’s Research Institute. She has led the design and analysis of numerous clinical studies which have advanced clinical care and outcomes in CF. Dr. Hamblett directs the TDN Consulting Program which partners with industry sponsors and regulators to strategize on complex drug development issues relevant to rare diseases. She is currently a principal investigator on therapeutic trials optimizing treatment regimens in CF and studies to advance biomarkers supporting therapeutic development for novel CFTR modulator therapies. In addition, she collaborates with investigators on epidemiologic studies to identify risk factors for morbidity and mortality in the pediatric disease setting. Dr. Hamblett provides statistical and study design mentorship and training to clinical researchers and scientists, with applications to both the preclinical and clinical fields.
S11--Nucleotide-Based Therapeutics Across Diverse Populations
Thursday, September 26, 2024
2:30 PM – 4:30 PM ET
S11.2- Clinical Trial Design & Recruitment Considerations to Advance a Pipeline of NABTs
Thursday, September 26, 2024
2:30 PM – 4:30 PM ET
Friday, September 27, 2024
2:30 PM – 4:30 PM ET